Complete Stock Availability: Your Treatment Options Explained
Ozempic vs Mounjaro vs Wegovy: Understanding UK Availability
When comparing Ozempic vs Mounjaro vs Wegovy, the first crucial distinction is licensing. Ozempic, whilst containing the same active ingredient as Wegovy (semaglutide), is licensed exclusively for type 2 diabetes management in the UK. Promoting or prescribing Wegovy for weight management constitutes off-label use and is not supported by UK licensing authorities. Both Mounjaro (tirzepatide) and Wegovy (semaglutide) hold specific MHRA approvals for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. At EverydayMeds, we maintain consistent stock levels of both licensed weight management options, ensuring you can access your prescribed treatment without the supply disruptions that have affected the market previously.
The availability advantage extends beyond simple stock levels to reliable prescription fulfilment. Our GPhC-registered pharmacy (#9012878) has established robust supply chains with both Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro), enabling us to process orders within 24 hours of prescription approval. Unlike many providers who operate waitlists or uncertain delivery timescales, we ensure next-day delivery once your clinical assessment is complete. This reliability proves essential for maintaining consistent dosing schedules, particularly during the critical dose escalation phases that both Mounjaro and Wegovy require. Whether you're starting treatment or transitioning between doses, our stock availability removes the anxiety of treatment interruption that many patients have experienced elsewhere.
Wegovy vs Mounjaro Pricing: Complete UK Cost Comparison
Understanding the full cost implications when comparing Ozempic vs Mounjaro vs Wegovy requires examining both individual dose pricing and bundle options. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99 (with FIRST40 discount applied at checkout), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle (0.25mg & 0.5mg) provides the first two months of treatment for £169.99, whilst the Ultimate Stability Trio offers three months of 2.4mg maintenance doses for £649.99. Returning customers benefit from our DOSE25 discount code, applied automatically at checkout to reach these final prices.
Mounjaro follows a different dose escalation pattern with its own pricing structure, though both treatments require similar long-term financial commitment for sustained weight management. When evaluating the true cost of either option, consider that clinical trials demonstrate weight regain occurs when treatment stops - making ongoing treatment necessary for maintained results. Our bundle options provide supply security and convenience, reducing the frequency of reordering whilst ensuring consistent treatment availability. The prescription-only medicine status of both treatments means ongoing prescriber oversight, with our clinical team available to support treatment adjustments and address any concerns throughout your weight management journey.
Clinical Evidence: Ozempic vs Mounjaro vs Wegovy Research
The clinical evidence base differs significantly between these three options when used for weight management. Wegovy's efficacy is demonstrated through the comprehensive STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise interventions (Wilding et al., NEJM, 2021). The STEP 5 trial confirmed sustained weight loss of approximately 15.2% at two years, whilst the recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. These results represent averages from clinical trial populations and individual responses may vary considerably.
Mounjaro's evidence comes from the SURMOUNT trial series, demonstrating its dual GIP and GLP-1 receptor mechanism in weight management contexts. However, directly comparing percentage weight loss between Wegovy and Mounjaro trials would be misleading, as the studies employed different populations, endpoints, and methodological approaches. Both treatments require administration alongside a reduced-calorie diet and increased physical activity to achieve optimal results. The prescription-only medicine classification ensures that treatment decisions consider your individual medical history, current medications, and specific weight management goals rather than relying solely on clinical trial averages.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of natural incretin hormones produced in your intestines after eating. This mechanism differs fundamentally from Mounjaro's dual GIP and GLP-1 approach, offering single-pathway appetite regulation through brain-gut communication. The medication works by slowing gastric emptying, meaning food remains in your stomach longer, promoting earlier satiety signals during meals. Additionally, semaglutide acts on appetite centres in the hypothalamus, potentially reducing food cravings and the psychological drive to eat between meals. The once-weekly injection schedule using the FlexTouch pen device provides consistent medication levels throughout the week, avoiding the daily dosing requirements of some other weight management approaches. This sustained action supports gradual, progressive weight loss when combined with lifestyle modifications rather than rapid changes that may be difficult to maintain long-term.
Simple Ordering Process: From Assessment to Delivery
Accessing Wegovy through EverydayMeds begins with our streamlined 3-minute online clinical assessment, designed to gather essential medical history and current health information. This comprehensive questionnaire covers existing medications, previous weight management attempts, relevant medical conditions, and treatment goals to ensure Wegovy is appropriate for your circumstances. Following assessment submission, our qualified prescribers review your information within standard 3 working days, or express 24-hour service if urgently required. Once approved, your prescription enters our fulfilment system for immediate processing and next-day cold-chain delivery. Our temperature-controlled delivery service maintains the 2-8°C storage requirements throughout transit, ensuring medication efficacy upon arrival. All orders include comprehensive patient information leaflets, injection technique guidance, and direct contact details for our clinical support team throughout your treatment journey.
Storage and Practical Considerations for UK Patients
Wegovy storage requirements offer practical advantages when comparing treatment options, particularly for UK patients with active lifestyles or travel requirements. The medication must be stored in the refrigerator at 2-8°C before first use, but once removed, can remain at room temperature (below 30°C) for up to 6 weeks. This flexibility significantly exceeds Mounjaro's 21-day room temperature tolerance, making Wegovy more suitable for extended travel or situations where refrigeration access is limited. The FlexTouch pen device features a simple, user-friendly design with clear dose windows and audible click confirmations during injection. Dose escalation follows a mandatory schedule: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and 2.4mg for maintenance from week 17 onwards. Each dose increase allows your body to gradually adjust to higher semaglutide levels, minimising potential gastrointestinal side effects whilst optimising weight management benefits.
Why UK Stock Availability Matters for Ozempic vs Mounjaro vs Wegovy
The global supply challenges affecting weight management medications have created significant treatment disruption for UK patients, making reliable stock availability a critical factor in treatment selection. Interrupting dose escalation schedules or experiencing gaps between pen supplies can compromise treatment efficacy and necessitate restarting from lower doses. Our commitment to maintaining comprehensive Wegovy stock across all five dose strengths ensures continuity throughout your treatment journey. This reliability extends to our Mounjaro supply chain, providing genuine choice between the two licensed weight management options rather than defaulting to whichever medication happens to be available.
Stock security also enables proper treatment planning with your prescriber, allowing dose adjustments based on clinical response rather than supply constraints. Many patients have experienced the frustration of prescription approval followed by indefinite waiting periods or automatic substitutions that may not align with their treatment plan. At EverydayMeds, our inventory management systems provide real-time stock visibility, enabling accurate delivery commitments and eliminating the uncertainty that has characterised weight management medication access. This reliability proves particularly valuable for patients requiring consistent treatment to maintain weight loss achievements, as research demonstrates that treatment interruption can lead to rapid weight regain.
Start Your Treatment Today: No Waiting, No Delays
Ready to begin your weight management journey without the delays that have frustrated so many UK patients? EverydayMeds provides immediate access to both Wegovy and Mounjaro through our streamlined prescription service, with new customers saving through our FIRST40 discount code and returning patients benefiting from DOSE25 at checkout. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and join thousands of patients who have chosen reliable, professional weight management support. Our clinical team stands ready to guide you through treatment selection, ensuring you receive the most appropriate medication for your individual circumstances. Whether you choose Wegovy's established GLP-1 approach or Mounjaro's innovative dual mechanism, you can trust our GPhC-registered pharmacy (#9012878) to deliver consistent, professional service throughout your treatment journey. Take the first step towards sustainable weight management with confidence, knowing your medication will be there when you need it.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
